Nigericin sodium salt
Nigericin sodium salt (CAS: 28643-80-3) is the sodium salt of nigericin. Nigericin reversibly binds K+ through coordination of the cation by its polyether oxygen atoms, forming a neutral, membrane-permeable complex that diffuses across the lipid bilayer. After releasing K+ on the opposite side of the membrane, nigericin binds H+ and transports it in the reverse direction. Through repeated cycles of K+ binding, transmembrane diffusion, ion exchange, and proton return, nigericin mediates exchange of K+ and H+ across biological membranes without generating a net electrical current. This process rapidly dissipates transmembrane K+ and proton gradients, resulting in intracellular K+ depletion and cytosolic acidification.
In inflammasome research, nigericin is widely used as a potent activator of the NLRP3 inflammasome and a classical inducer of pyroptosis. Following lipopolysaccharide (LPS)-mediated priming, nigericin promotes rapid K+ efflux, which lowers intracellular potassium concentrations below the threshold required to maintain the inactive conformation of NLRP3. The resulting conformational change triggers NLRP3 oligomerization and recruitment of the adaptor protein ASC through pyrin domain (PYD)-PYD interactions. ASC subsequently recruits pro-caspase-1 via caspase recruitment domain (CARD)-CARD interactions, leading to inflammasome assembly and caspase-1 activation. Activated caspase-1 cleaves gasdermin D (GSDMD) to generate its pore-forming N-terminal fragment and processes the precursor forms of interleukin-1β (IL-1β) and interleukin-18 (IL-18) into their mature cytokines. GSDMD-mediated plasma membrane pore formation ultimately results in cell swelling, membrane rupture, cytokine release, and pyroptotic cell death.
In addition to its widespread application in inflammasome studies, nigericin has been extensively used to investigate ion transport and bioenergetics. In Na⁺-containing media, nigericin has little effect on ADP-induced platelet aggregation but only modestly inhibits thrombin-induced platelet aggregation, an effect that has been attributed primarily to nigericin-induced cytosolic acidification rather than alterations in potassium homeostasis. Nigericin has also been reported to function as an efficient ion carrier for Pb2+, and physiological concentrations of Ca2+ or Mg2+ have minimal influence on nigericin-mediated Pb2+ transport, whereas varying concentrations of K+ or Na+ produce only minor effects, suggesting potential applications in studies of lead detoxification. Furthermore, nigericin modulates mitochondrial energy metabolism by inhibiting ATP-driven transhydrogenase activity over a broad range of ATP concentrations, with more pronounced inhibition observed at lower ATP levels, while simultaneously stimulating the carbonyl reduction reaction under saturating ATP conditions.
Reference:
1. P. Rozario, M. Pinilla, L. Gorse, A.C. Vind, K.S. Robinson, G.A. Toh, M.J. Firdaus, J.F. Martínez, S.K. Kerk, Z. Lin, J.C. Chambers, S. Bekker-Jensen, E. Meunier, & F. Zhong, Mechanistic basis for potassium efflux–driven activation of the human NLRP1 inflammasome, Proc. Natl. Acad. Sci. U.S.A. 121 (2) e2309579121, https://doi.org/10.1073/pnas.2309579121 (2024).
2. den Hartigh AB, Fink SL. Pyroptosis Induction and Detection. Curr Protoc Immunol. 2018 Aug;122(1):e52. doi: 10.1002/cpim.52. Epub 2018 Jul 20. PMID: 30028908; PMCID: PMC6339837.
3. Kitagawa S, Awai M, Kametani F. Relationship of the effects of nigericin on the aggregation and cytoplasmic pH of bovine platelets in the presence of different cations. Biochim Biophys Acta, 1987, 930(1): 48-54.
4. Hamidinia SA, Tan B, Erdahl WL, et al. The ionophore nigericin transports Pb2+ with high activity and selectivity: a comparison to monensin and ionomycin. Biochemistry, 2004, 43(50): 15956-15965.
5. Eytan GD, Carlenor E, Rydström J. Energy-linked transhydrogenase. Effects of valinomycin and nigericin on the ATP-driven transhydrogenase reaction catalyzed by reconstituted transhydrogenase-ATPase vesicles. J Biol Chem, 1990, 265(22): 12949-12954.
- 1. Nicholas W Harper, Gavin A Birdsall, et al. "RNA Pol II inhibition activates cell death independently from the loss of transcription." Cell. 2025 Aug 14:S0092-8674(25)00856-6. PMID: 40818455
- 2. Nicholas W. Harper, Gavin A. Birdsall, et al. "Pol II degradation activates cell death independently from the loss of transcription." bioRxiv. 2025 Jan 14:2024.12.09.627542. PMID: 39713309
- 3. Lvyuan Fan, Zhiyu Pan, et al. "L-glutamine sensitizes Gram-positive-resistant bacteria to gentamicin killing." Microbiol Spectr. 2023 Dec 12;11(6):e0161923. PMID: 37882580
- 4. Yuan-Li Ai, Wei-Jia Wang, et al. "Mannose antagonizes GSDME-mediated pyroptosis through AMPK activated by metabolite GlcNAc-6P." Cell Res. 2023 Jul 17. PMID: 37460805
- 5. Schwartz, Hannah, et al. "In vitro Methods to Better Evaluate Drug Responses in Cancer." UMass Chan Medical School. September 8, 2022.
- 6. Di Wu, Xiangyu Zhu, et al. "Delivery of Ultrasmall Nanoparticles to the Cytosolic Compartment of Pyroptotic J774A.1 Macrophages via GSDMDNtermMembrane Pores." ACS Appl Mater Interfaces. 2021 Nov 3;13(43):50823-50835. PMID: 34689556
- 7. Wang J, Luo J, et al. "Increased intracellular Cl(-) concentration by activating FAK promotes airway epithelial BEAS-2B cells proliferation and wound healing." Arch Biochem Biophys. 2019 Dec 12:108225. PMID: 31838119
- 8. Antonopoulos, Christina, et al. "Caspase-8 as an Effector and Regulator of NLRP3 Inflammasome Signaling." Journal of Biological Chemistry (2015): jbc-M115. PMID: 26100631
| Storage | Desiccate at -20°C away from light |
| M.Wt | 746.94 |
| Cas No. | 28643-80-3 |
| Formula | C40H67NaO11 |
| Solubility | insoluble in H2O; insoluble in DMSO; ≥74.7 mg/mL in EtOH |
| Chemical Name | sodium (S)-2-((2R,3S,6R)-6-(((2S,4S,5R,7R,9S,10R)-2-((2R,2'R,3'S,5R,5'R)-5'-((2S,3S,5R,6R)-6-hydroxy-6-(hydroxymethyl)-3,5-dimethyltetrahydro-2H-pyran-2-yl)-2,3'-dimethyloctahydro-[2,2'-bifuran]-5-yl)-9-methoxy-2,4,10-trimethyl-1,6-dioxaspiro[4.5]decan-7- |
| Canonical SMILES | O[C@@]1(CO)O[C@@H]([C@@H](C)C[C@H]1C)[C@@H]2O[C@H]([C@@H](C)C2)[C@]3(C)O[C@H](CC3)[C@@]4(C)O[C@]([C@@H](C)C4)([C@@H]5C)O[C@H](C[C@@H]6O[C@@H]([C@@H](C([O-])=O)C)[C@@H](C)CC6)C[C@@H]5OC.[Na+] |
| Shipping Condition | Small Molecules with Blue Ice, Modified Nucleotides with Dry Ice. |
| General tips | We do not recommend long-term storage for the solution, please use it up soon. |
| Cell Experiment [1]: | |
|
Clone |
Blood Latelets |
|
Preparation Method |
Solubility <3.7 mg/mL in DMSO. If a higher concentration of solution, the general steps are as follows: please send a test tube heating at 37°C for 10 minutes and/or place it in the ultrasonic bath in shock for a period of time. Concentrate on -20°C can be placed for months. |
|
Reaction Condition |
2 μM;2minutes |
|
Experimental Result |
In medium of K+ (combined with ion carrier, with the highest permeability), Nigericin Sodium Salt enhanced platelet aggregation. However, in the medium of choline (combined with ion carrier, has relatively low permeability), Nigericin Sodium Salt inhibited platelet aggregation. In addition, relative to the platelet aggregation rate, Nigericin Sodium Salt have a greater influence on the maximum of platelet aggregation. |
|
References: [1]. Kitagawa S, Awai M, Kametani F. Relationship of the effects of nigericin on the aggregation and cytoplasmic pH of bovine platelets in the presence of different cations. Biochim Biophys Acta, 1987, 930(1): 48-54. |
|
Quality Control & MSDS
- View current batch:
Chemical structure

Related Biological Data

Related Biological Data

Related Biological Data













